Skip to main content
OpenTrials
Completed

NCT Number: NCT02264561

Caffeine's Effect on Attention

The purpose of this study is to determine whether caffeine improves attention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Attention

Age range

40 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Center for Human Drug Research

Leiden, CL, 2333, Netherlands

About this study

Single centre single dose cross-over, placebo-controlled, double blind, randomized trial with two treatment conditions : caffeine and placebo

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Healthy male and female Aged 40-60 years

Treatment and study plan

Food

Other

Active group

Other names: Caffeine

Primary outcomes

  1. Attention test: milliseconds and index of stimulus sensitivity

    Time frame: duration 10 days from screening to last visit (V2)

Secondary outcomes

  1. Central Nervous System :response time.

    Time frame: duration: 10 days from screening to last visit (V2)

  2. Mood measures: Visual Analog scale.

    Time frame: duration 10 days from screening to last visit V2

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Société des Produits Nestlé (SPN)

Industry

Registry information

Official study title

The Effect of Caffeine on Attention

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Oct 15, 2014
Registry last updated
Apr 8, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.